查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930157

解剖病理市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察，2026-2034年

Anatomic Pathology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 請詢問到貨日

價格

解剖病理市場成長驅動因素

受慢性病盛行率上升和對精準疾病診斷需求不斷成長的推動，全球解剖病理市場預計在預測期內將顯著成長。該市場預計在2025年達到 377.4億美元，並在2026年達到 402.9億美元。預計到2034年將進一步成長至 740.4億美元，年複合成長率（CAGR）為 7.90%。北美地區在2025年將以 36.18%的市場佔有率領先，這主要得益於其先進的醫療基礎設施、高檢測量以及創新病理技術的廣泛應用。

解剖病理學是一門透過檢查組織、器官和體液來診斷疾病的專科。它在癌症檢測、發炎性疾病評估和慢性病管理中發揮著非常重要的作用。根據美國癌症協會（2025年）估計，美國每年新增癌症病例約200萬例，這進一步推動了對解剖病理學檢測（包括解剖病理學檢測、免疫組織化學和分子診斷）的需求。

主要市場參與者，例如 Cardinal Health、F. Hoffmann-La Roche Ltd. 和 Leica Microsystems，正致力於開發創新儀器、耗材和人工智慧驅動的數位病理學解決方案，以滿足不斷成長的患者群體和對早期疾病檢測的需求。

市場動態

市場驅動因素

癌症、自體免疫疾病和發炎性腸道疾病等慢性疾病的日益普遍，推動解剖病理學產品的應用。根據美國疾病管制與預防中心（CDC）（2024）的資料顯示，發炎性腸道疾病影響著美國 240萬至 310萬人。此外，早期檢測和篩檢技術的進步，以及人工智慧（AI）與數位解剖病理學的融合，推動全球檢測量的成長。

其他主要成長驅動因素包括：

  • 精準醫療的興起：生物標記檢測與組織解剖病理學的融合，能夠實現個人化治療決策。
  • 醫療基礎設施的擴建：醫院、診斷中心和實驗室現代化方案的增加，尤其是在亞太和拉丁美洲地區，推動市場滲透。
  • 支持性償付計畫：政府和保險公司擴大診斷檢測的覆蓋範圍，特別是癌症篩檢。

市場限制因子

全切片成像系統、切片機、染色機和組織處理系統等先進產品的高昂成本限制了它們的普及，尤其是在中小型實驗室。額外的營運成本、切片製備和監管合規性進一步限制了產品的普及。

市場機會

針對癌症治療的臨床試驗的增加，為製造商和檢測機構與合約研究組織（CRO）合作創造了機會。生物標記評估、基於組織的伴隨診斷和組織解剖病理學評估在免疫療法和基因療法的臨床試驗中變得越來越重要，推動了對先進分子解剖病理學和數位解剖病理學平台的需求。

市場挑戰

  • 發展中國家的診斷限制：發表時間延遲、熟練病理學家短缺以及實驗室基礎設施不足阻礙了早期檢測。
  • 監管障礙：基於人工智慧和分子解剖病理解決方案的漫長驗證和審批流程延緩了商業化進程。
  • 替代技術的出現：液體切片檢查和先進影像技術正開始補充或取代傳統病理方法。

市場趨勢

人工智慧、數位解剖病理、分子診斷和全切片成像等技術進步改變市場格局。根據梅奧診所（2025年）預測，超過 50%的外科病理病例將數位化，並透過數位平台進行解讀，提高診斷準確性和工作流程效率。

市場區隔分析

依類型

市場分為產品與服務兩大類。產品（設備和耗材，例如切片機、染色機和組織處理系統）佔據市場主導地位，預計到2026年將佔據 63.13%的市場佔有率，這主要得益於解剖病理學檢測的增加和監管審批的推進。

例如：2024年 5月，Indica Labs 的主要診斷數位平台 "HALO AP Dx" 獲得 FDA 批准，進一步豐富了其產品組合。

依應用

  • 疾病診斷預計將佔據市場主導地位，預計到2026年將佔據 71.64%的市場佔有率，這主要得益於癌症和自體免疫疾病等慢性病盛行率的上升。
  • 藥物研發領域將以 7.7%的年複合成長率成長。

依技術劃分

  • 受慢性病發病率上升的推動，組織解剖病理學預計在2026年佔據45.62%的市場佔有率。
  • 分子解剖病理學預計將以8.3%的年複合成長率成長，這反映了先進診斷方法的日益普及。

依最終使用者劃分

  • 受醫療機構數量增加和患者群體擴大的推動，醫院和門診手術中心（ASC）將在2026年佔據56.54%的市場佔有率。
  • 臨床實驗室預計將以7.7%的年複合成長率成長。

區域展望

  • 北美：預計2025年市場規模將達到136.5億美元，2026年將達到146.3億美元，其中美國將佔126.9億美元。這主要得益於高檢測量和先進的基礎設施。
  • 歐洲：預計2026年市場規模將達到99.8億美元，主要得益於監管合規、數位化解剖病理學的應用以及醫療保健服務的改善。
  • 亞太地區：預計2026年市場規模將達到117.8億美元，其中印度將佔24億美元，中國將佔36.2億美元。
  • 拉丁美洲：預計到2026年，市場規模將達到 25.3億美元。
  • 中東和非洲：預計到2025年，GCC地區的市場規模將達到 3.7億美元。

主要產業趨勢

  • 2025年 9月：Labcorp 收購Roche的VENTANA DP 600 和 DP200 掃描器。
  • 2025年 9月：StatLab Medical Products 推出 PiSmart S1 玻片印表機。
  • 2025年 7月：PathAI 推出精準病理網路（PPN），該網路配備 AISight 1 IMS。
  • 2025年 3月：Techcyte 推出其 Fusion SaaS 平台，該平台整合了解剖學和臨床工作流程。
  • 2024年8月：StatLab收購Diapath S.p.A.，以增強其市場佔有率。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要疾病流行情況、主要國家和地區（2025/2026年）
  • 新產品發布、主要參與者
  • 關鍵產業趨勢 - 併購與合作

第5章 全球解剖病理學市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測 - 依類型劃分
    • 產品
      • 設備
      • 耗材
    • 服務
  • 市場分析、洞察與預測 - 依應用劃分
    • 疾病診斷
    • 藥物研發
    • 其他
  • 市場分析、洞察與預測 - 依技術劃分
    • 組織解剖病理學
    • 免疫組織化學（IHC）
    • 原位雜交
    • 分子解剖病理學
    • 其他
  • 市場分析、洞察與預測 - 依最終用戶劃分
    • 醫院及門診手術中心（門診手術中心）
    • 專科診所
    • 臨床實驗室
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美解剖病理市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲解剖病理市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第8章 亞太地區解剖病理學市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 亞太其他地區

第9章 拉丁美洲解剖病理學市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區美國

第10章 中東和非洲解剖病理學市場分析、洞察與預測（2021-2034年）

  • 依國家劃分
    • GCC
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
  • Cardinal Health
  • F. Hoffmann La. Roche Ltd.
  • Avantor, Inc.
  • Danaher Corporation
  • SLMP, LLC.
  • Agilent Technologies, Inc.
  • Indica Labs, LLC.
  • Hologic, Inc.
Product Code: FBI114388

Growth Factors of anatomic pathology Market

The global anatomic pathology market is poised for substantial growth over the forecast period, driven by the increasing prevalence of chronic diseases and the rising demand for accurate disease diagnosis. The market was valued at USD 37.74 billion in 2025, projected to reach USD 40.29 billion in 2026, and is expected to grow to USD 74.04 billion by 2034, reflecting a CAGR of 7.90%. North America led the market in 2025 with a 36.18% share, attributed to advanced healthcare infrastructure, high test volumes, and widespread adoption of innovative pathology technologies.

Anatomic pathology, a specialty focusing on the diagnosis of diseases through the examination of tissues, organs, and bodily fluids, plays a critical role in cancer detection, inflammatory disease evaluation, and chronic condition management. According to the American Cancer Society (2025), approximately 2 million new cancer cases are estimated in the U.S., further bolstering the demand for anatomic pathology tests, including histopathology, immunohistochemistry, and molecular diagnostics.

Leading market players, such as Cardinal Health, F. Hoffmann-La Roche Ltd., and Leica Microsystems, are focusing on innovative instruments, consumables, and AI-enabled digital pathology solutions to address the growing patient population and demand for early disease detection.

Market Dynamics

Market Drivers

Increasing prevalence of chronic disorders such as cancer, autoimmune disorders, and inflammatory bowel diseases is driving the adoption of anatomic pathology products. According to the CDC (2024), inflammatory bowel disease affects 2.4-3.1 million people in the U.S. Moreover, advancements in early detection and screening, coupled with the integration of artificial intelligence (AI) and digital pathology, are increasing test volumes globally.

Other key growth drivers include:

  • Shift toward precision medicine: Integration of biomarker testing with anatomic pathology enables personalized treatment decisions.
  • Expanding healthcare infrastructure: Growth in hospitals, diagnostic centers, and laboratory modernization projects, particularly in Asia Pacific and Latin America, is increasing market penetration.
  • Supportive reimbursement programs: Governments and insurers are expanding coverage for diagnostic tests, particularly for cancer screening.

Market Restraints

High costs associated with advanced products such as whole-slide imaging systems, microtomes, stainers, and tissue processing systems limit adoption, especially in small and mid-sized labs. Additional operational costs, slide preparation, and regulatory compliance further constrain product penetration.

Market Opportunities

The rising number of oncology-focused clinical trials is creating opportunities for manufacturers and laboratories to collaborate with contract research organizations. Biomarker assessment, tissue-based companion diagnostics, and histopathologic evaluation are increasingly critical in immunotherapy and gene therapy trials, boosting demand for advanced molecular and digital pathology platforms.

Market Challenges

  • Limited diagnosis in developing countries: Delayed referrals, lack of skilled pathologists, and inadequate laboratory infrastructure hinder early detection.
  • Regulatory barriers: Lengthy validation and approval processes for AI-based and molecular pathology solutions slow commercialization.
  • Emergence of substitute technologies: Liquid biopsies and advanced imaging are starting to complement or replace traditional pathology methods.

Market Trends

Technological advancements such as AI, digital pathology, molecular diagnostics, and whole-slide imaging are transforming the market. According to the Mayo Clinic (2025), over 50% of surgical pathology cases were digitized and interpreted through digital platforms, enhancing diagnostic accuracy and workflow efficiency.

Segmentation Analysis

By Type

The market is segmented into products and services. Products, including instruments (microtomes, stainers, tissue processing systems) and consumables, dominated the market with a 63.13% share in 2026, driven by increasing anatomic pathology tests and regulatory approvals.

Example: In May 2024, Indica Labs received FDA approval for HALO AP Dx, a digital platform for primary diagnosis, strengthening its product portfolio.

By Application

  • Disease diagnosis dominated with a 71.64% share in 2026, owing to the rising prevalence of chronic conditions such as cancer and autoimmune disorders.
  • Drug discovery is projected to grow at a 7.7% CAGR.

By Technique

  • Histopathology accounted for 45.62% share in 2026, driven by increasing chronic disease incidence.
  • Molecular pathology is forecasted to grow at 8.3% CAGR, reflecting increasing adoption of advanced diagnostics.

By End User

  • Hospitals & ASCs led the market with a 56.54% share in 2026, supported by the rising number of healthcare facilities and patient pool.
  • Clinical laboratories are projected to grow at 7.7% CAGR.

Regional Outlook

  • North America: Market valued at USD 13.65 billion in 2025, projected to USD 14.63 billion in 2026, with the U.S. accounting for USD 12.69 billion, driven by high test volumes and advanced infrastructure.
  • Europe: Expected to reach USD 9.98 billion in 2026, supported by regulatory compliance, digital pathology adoption, and healthcare access.
  • Asia Pacific: Estimated at USD 11.78 billion in 2026, with India at USD 2.4 billion and China at USD 3.62 billion.
  • Latin America: Projected to reach USD 2.53 billion in 2026.
  • Middle East & Africa: GCC expected at USD 0.37 billion in 2025.

Competitive Landscape

Key players include Cardinal Health, Hoffmann-La Roche Ltd., Avantor Inc., Danaher Corporation, SLMP LLC, Agilent Technologies, Indica Labs, and Hologic Inc. Strategic initiatives such as product launches, FDA approvals, acquisitions, and collaborations support market dominance.

Example: In June 2024, F. Hoffmann-La Roche Ltd. received FDA approval for the VENTANA DP 200 whole-slide imaging system, enhancing global product offerings.

Key Industry Developments

  • September 2025: Labcorp implemented Roche's VENTANA DP 600 and DP 200 scanners.
  • September 2025: StatLab Medical Products launched PiSmart S1 slide printer.
  • July 2025: PathAI introduced its Precision Pathology Network (PPN), powered by AISight 1 IMS.
  • March 2025: Techcyte launched Fusion SaaS platform for unified anatomic and clinical workflows.
  • August 2024: StatLab acquired Diapath S.p.A. to strengthen its market presence.

Conclusion

The global anatomic pathology market is projected to grow from USD 37.74 billion in 2025 to USD 74.04 billion by 2034, at a CAGR of 7.90%, driven by increasing chronic disease prevalence, technological advancements, and expanding healthcare infrastructure. North America leads the market, while emerging regions present significant growth potential. Adoption of AI-enabled digital pathology, molecular diagnostics, and regulatory-approved instruments is expected to drive global market expansion, providing accurate, efficient, and personalized diagnostic solutions across the healthcare spectrum.

Segmentation By Type, Application, Technique, End User, and Region

By Type * Products

    • Instruments
      • Microtomes
      • Tissue Processing Systems
      • Stainers
      • Others
    • Consumables
  • Services

By Application * Disease Diagnosis

  • Drug Discovery
  • Others

By Technique * Histopathology

  • Immunohistochemistry (IHC)
  • In-situ Hybridization
  • Molecular Pathology
  • Others

By End User * Hospitals & ASCs

  • Specialty Clinics
  • Clinical Laboratories
  • Others

By Region * North America (By Type, By Application, By Technique, By End User, and by Country)

    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • U.K. (By Application)
    • Germany (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • GCC (By Application)
    • South Africa (By Application)
    • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
  • 4.2. New Product Launches, Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Products
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Microtomes
        • 5.1.1.1.2. Tissue Processing Systems
        • 5.1.1.1.3. Stainers
        • 5.1.1.1.4. Others
      • 5.1.1.2. Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Disease Diagnosis
    • 5.2.2. Drug Discovery
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Technique
    • 5.3.1. Histopathology
    • 5.3.2. Immunohistochemistry (IHC)
    • 5.3.3. In-situ Hybridization
    • 5.3.4. Molecular Pathology
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Hospitals & ASCs
    • 5.4.2. Specialty Clinics
    • 5.4.3. Clinical Laboratories
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Products
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Microtomes
        • 6.1.1.1.2. Tissue Processing Systems
        • 6.1.1.1.3. Stainers
        • 6.1.1.1.4. Others
      • 6.1.1.2. Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Disease Diagnosis
    • 6.2.2. Drug Discovery
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Technique
    • 6.3.1. Histopathology
    • 6.3.2. Immunohistochemistry (IHC)
    • 6.3.3. In-situ Hybridization
    • 6.3.4. Molecular Pathology
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Hospitals & ASCs
    • 6.4.2. Specialty Clinics
    • 6.4.3. Clinical Laboratories
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Application
    • 6.5.2. Canada
      • 6.5.2.1. By Application

7. Europe Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Products
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Microtomes
        • 7.1.1.1.2. Tissue Processing Systems
        • 7.1.1.1.3. Stainers
        • 7.1.1.1.4. Others
      • 7.1.1.2. Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Disease Diagnosis
    • 7.2.2. Drug Discovery
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Technique
    • 7.3.1. Histopathology
    • 7.3.2. Immunohistochemistry (IHC)
    • 7.3.3. In-situ Hybridization
    • 7.3.4. Molecular Pathology
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Hospitals & ASCs
    • 7.4.2. Specialty Clinics
    • 7.4.3. Clinical Laboratories
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Application
    • 7.5.2. Germany
      • 7.5.2.1. By Application
    • 7.5.3. France
      • 7.5.3.1. By Application
    • 7.5.4. Spain
      • 7.5.4.1. By Application
    • 7.5.5. Italy
      • 7.5.5.1. By Application
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Application
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Application

8. Asia Pacific Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Products
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Microtomes
        • 8.1.1.1.2. Tissue Processing Systems
        • 8.1.1.1.3. Stainers
        • 8.1.1.1.4. Others
      • 8.1.1.2. Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Disease Diagnosis
    • 8.2.2. Drug Discovery
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Technique
    • 8.3.1. Histopathology
    • 8.3.2. Immunohistochemistry (IHC)
    • 8.3.3. In-situ Hybridization
    • 8.3.4. Molecular Pathology
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Specialty Clinics
    • 8.4.3. Clinical Laboratories
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Application
    • 8.5.2. Australia
      • 8.5.2.1. By Application
    • 8.5.3. China
      • 8.5.3.1. By Application
    • 8.5.4. India
      • 8.5.4.1. By Application
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Application
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Application

9. Latin America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Products
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Microtomes
        • 9.1.1.1.2. Tissue Processing Systems
        • 9.1.1.1.3. Stainers
        • 9.1.1.1.4. Others
      • 9.1.1.2. Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Disease Diagnosis
    • 9.2.2. Drug Discovery
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Technique
    • 9.3.1. Histopathology
    • 9.3.2. Immunohistochemistry (IHC)
    • 9.3.3. In-situ Hybridization
    • 9.3.4. Molecular Pathology
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Hospitals & ASCs
    • 9.4.2. Specialty Clinics
    • 9.4.3. Clinical Laboratories
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Application
    • 9.5.2. Mexico
      • 9.5.2.1. By Application
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Application

10. Middle East & Africa Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Products
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Microtomes
        • 10.1.1.1.2. Tissue Processing Systems
        • 10.1.1.1.3. Stainers
        • 10.1.1.1.4. Others
      • 10.1.1.2. Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Disease Diagnosis
    • 10.2.2. Drug Discovery
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Technique
    • 10.3.1. Histopathology
    • 10.3.2. Immunohistochemistry (IHC)
    • 10.3.3. In-situ Hybridization
    • 10.3.4. Molecular Pathology
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Hospitals & ASCs
    • 10.4.2. Specialty Clinics
    • 10.4.3. Clinical Laboratories
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
      • 10.5.1.1. By Application
    • 10.5.2. South Africa
      • 10.5.2.1. By Application
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Cardinal Health
    • 11.2.2. F. Hoffmann La. Roche Ltd.
    • 11.2.3. Avantor, Inc.
    • 11.2.4. Danaher Corporation
    • 11.2.5. SLMP, LLC.
    • 11.2.6. Agilent Technologies, Inc.
    • 11.2.7. Indica Labs, LLC.
    • 11.2.8. Hologic, Inc.

List of Tables

  • Table 1: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 4: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 6: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 9: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 10: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 11: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 12: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 13: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Anatomic Pathology Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: U.S. Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Canada Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 18: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 19: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 20: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 21: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 22: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 23: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 24: Germany Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 25: U.K. Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 26: France Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Italy Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Spain Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Scandinavia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 30: Rest of Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 31: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 33: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 34: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 36: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 37: China Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 38: Japan Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 39: India Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 40: Australia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Southeast Asia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 42: Rest of Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 43: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 44: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 45: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 46: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 47: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 48: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 49: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 50: Brazil Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 51: Mexico Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 52: Rest of Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 53: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 54: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 55: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 56: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 57: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 58: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 59: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 60: GCC Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 61: South Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 62: Rest of Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034

List of Figures

  • Figure 1: Global Anatomic Pathology Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Anatomic Pathology Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Anatomic Pathology Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Anatomic Pathology Market Value Share (%), by Technique, 2025 & 2034
  • Figure 5: Global Anatomic Pathology Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Anatomic Pathology Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 8: North America Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 9: North America Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 10: North America Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 11: North America Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 12: North America Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 13: North America Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 15: North America Anatomic Pathology Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Anatomic Pathology Market Value Share (%), By Country, 2025
  • Figure 17: Europe Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 19: Europe Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 20: Europe Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 21: Europe Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 22: Europe Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 23: Europe Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 25: Europe Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 30: Asia Pacific Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 31: Asia Pacific Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 32: Asia Pacific Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 33: Asia Pacific Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 40: Latin America Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 41: Latin America Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 42: Latin America Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 43: Latin America Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 50: Middle East & Africa Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 51: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 52: Middle East & Africa Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 53: Middle East & Africa Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Anatomic Pathology Market Share (%), By Company, 2025